CIK 0001649904 · Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462159271
- Phone
- 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-08 | Cramer Pamela J. Chief Human Resources Officer | Option exercise 10b5-1 | +6,700 | $27.35 | $183K | 39,969 |
| 2025-04-08 | Cramer Pamela J. Chief Human Resources Officer | Sale 10b5-1 | −6,430 | $58.36 | $375K | 33,539 |
| 2025-04-08 | Cramer Pamela J. Chief Human Resources Officer | Sale 10b5-1 | −600 | $59.00 | $35K | 32,939 |
| 2025-04-08 | Cramer Pamela J. Chief Human Resources Officer | Sale 10b5-1 | −6,700 | $60.00 | $402K | 26,239 |
| 2025-04-08 | Cramer Pamela J. Chief Human Resources Officer | Sale 10b5-1 | −7,030 | $62.00 | $436K | 19,209 |
| 2025-04-08 | Cramer Pamela J. Chief Human Resources Officer | Option exercise · Stock Options (Right to Buy) 10b5-1 | +14,060 | 42,190 | ||
| 2025-04-08 | Cramer Pamela J. Chief Human Resources Officer | Option exercise · Stock Options (Right to Buy) 10b5-1 | +6,700 | 20,100 | ||
| 2025-04-08 | Mazabraud Yann EVP, Head of International | Sale 10b5-1 | −8,438 | $60.37 | $509K | 31,932 |
| 2025-04-08 | Mazabraud Yann EVP, Head of International | Sale 10b5-1 | −9,312 | $61.54 | $573K | 22,620 |
| 2025-03-21 | German Christopher Paul Corporate Controller & CAO | Sale | −344 | $54.23 | $19K | 2,889 |
| 2025-03-20 | German Christopher Paul Corporate Controller & CAO | Option exercise | +1,163 | 3,233 | ||
| 2025-03-20 | German Christopher Paul Corporate Controller & CAO | Option exercise · Restricted Stock Units | −1,163 | 2,324 | ||
| 2025-03-14 | Mazabraud Yann EVP, Head of International | Option exercise 10b5-1 | +75,000 | $22.28 | $1.7M | 115,370 |
| 2025-03-14 | Mazabraud Yann EVP, Head of International | Sale 10b5-1 | −19,197 | $50.79 | $975K | 96,173 |
| 2025-03-14 | Mazabraud Yann EVP, Head of International | Sale 10b5-1 | −55,803 | $51.72 | $2.9M | 40,370 |
| 2025-03-14 | Mazabraud Yann EVP, Head of International | Option exercise · Stock Options (Right to Buy) 10b5-1 | −75,000 | 25,000 | ||
| 2025-02-19 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −2,215 | $57.22 | $127K | 109,929 |
| 2025-02-19 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −1,228 | $57.22 | $70K | 8,509 |
| 2025-02-19 | Meeker David P President and CEO | Sale 10b5-1 | −9,896 | $57.22 | $566K | 201,281 |
| 2025-02-19 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −2,035 | $57.22 | $116K | 5,858 |
Page 16 of 19 · 376 trades